Eczema Steroids Treatments
Filters
Age
Severity
Side Effects
Age
Eczema Severity Level
Max Side Effects Tolerated
Treatment
Who is this for?
Delivery
Effectiveness
Side Effects
Estimated Cost
-
OVERALL HIGHEST EFFICACYHalobetasol(Halobetasol propionate)If you respond to corticosteroids and need short-term relief through a very strong steroidIf you respond to corticosteroids and need short-term relief through a very strong steroidTopical dailyMedium
Side Effect Affected Application site reactions 3% Skin dryness Itching at application site KEY TAKEAWAYSHalobetasol is highly effective at treating eczema, with success rates between 88-94% across multiple studies. Most patients see significant improvement or complete healing of their eczema.Study Summary Study Type Studied Population Results 📄Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Clinical Trial Total Patients: 264Severity: severeAge: Not specifiedAll three treatments showed similar high success rates 📄Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.Clinical Trial Total Patients: 120Halobetasol propionate showed better overall success rate The medication works quickly, with many patients seeing improvements within the first 3 days of treatment. This fast action makes it particularly useful for quick relief of symptoms.Study Summary Study Type Studied Population Results 📄Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.Clinical Trial Total Patients: 120Halobetasol propionate showed better overall success rate 📄Halobetasol propionate 0.05% ointment was significantly more effective than vehicle (placebo) in treating eczema. After 2 weeks of treatment, 83% of patients using halobetasol showed complete or marked improvement compared to 28% using vehicle. The medication was well-tolerated with no skin thinning reported.Clinical Trial Total Patients: 224Halobetasol was significantly more effective than vehicle in treating chronic eczema Halobetasol is generally safe and well-tolerated. Side effects are uncommon (occurring in only 2-5% of patients) and usually mild, mainly including skin dryness, itching, or burning sensations at the application site.Study Summary Study Type Studied Population Results 📄Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Clinical Trial Total Patients: 264Severity: severeAge: Not specifiedAll three treatments showed similar high success rates 📄Halobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The cream improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.Clinical Trial Total Patients: 111Severity: ChronicAge: Not specifiedSignificant improvement in all symptoms compared to vehicle (p<0.001) The medication is available in both cream and ointment forms, and can be effective in both adults and children. In pediatric patients, it showed excellent results with 100% success rate for eczema treatment.Study Summary Study Type Studied Population Results 📄Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Clinical Trial Total Patients: 264Severity: severeAge: Not specifiedAll three treatments showed similar high success rates Halobetasol propionate is highly effective at treating eczema, with success rates (defined as 'healed' or 'marked improvement') ranging from 88% to 94% in various studies. It starts working quickly, with many patients seeing improvement within 3 days of starting treatment.Study Summary Study Type Studied Population Results 📄Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Clinical Trial Total Patients: 264Severity: severeAge: Not availableAll three treatments showed similar high effectiveness 📄Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.Clinical Trial Total Patients: 120Halobetasol propionate showed better overall success rate The medication is generally well-tolerated with a low rate of side effects (2-5% of patients). The most common side effects are skin dryness, itching, or burning at the application site.Study Summary Study Type Studied Population Results 📄Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Clinical Trial Total Patients: 264Severity: severeAge: Not availableAll three treatments showed similar high effectiveness 📄Halobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The medication improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.Clinical Trial Total Patients: 111Significant improvement in all symptoms compared to vehicle by day 7 and day 14 (p<0.001) In children with severe eczema, the combination of halobetasol propionate cream during the day and ointment at night was extremely effective, with a 100% success rate. However, careful monitoring is needed as one case of mild skin thinning was reported.Study Summary Study Type Studied Population Results The medication performs as well as or better than other strong topical steroids like clobetasol propionate and betamethasone dipropionate, making it a reliable option for treating severe eczema.Study Summary Study Type Studied Population Results 📄Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Clinical Trial Total Patients: 264Severity: severeAge: Not availableAll three treatments showed similar high effectiveness 📄Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.Clinical Trial Total Patients: 120Halobetasol propionate showed better overall success rate -
OVERALL HIGHEST EFFICACYHalobetasol (Halobetasol propionate)Who is this for?:If you respond to corticosteroids and need short-term relief through a very strong steroidIf you respond to corticosteroids and need short-term relief through a very strong steroidEffectiveness:Side Effects:MediumCost:Delivery:Topical 1-2 dailySee EvidenceGet This TreatmentKEY TAKEAWAYS
Halobetasol is highly effective at treating eczema, with success rates between 88-94% across multiple studies. Most patients see significant improvement or complete healing of their eczema.
Summary:Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Study Type:Clinical TrialStudied Population:Total Patients: 264Severity: severeAge: Not specifiedResults:All three treatments showed similar high success rates
Summary:Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.Study Type:Clinical TrialStudied Population:Total Patients: 120Results:Halobetasol propionate showed better overall success rate
The medication works quickly, with many patients seeing improvements within the first 3 days of treatment. This fast action makes it particularly useful for quick relief of symptoms.
Summary:Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.Study Type:Clinical TrialStudied Population:Total Patients: 120Results:Halobetasol propionate showed better overall success rate
Summary:Halobetasol propionate 0.05% ointment was significantly more effective than vehicle (placebo) in treating eczema. After 2 weeks of treatment, 83% of patients using halobetasol showed complete or marked improvement compared to 28% using vehicle. The medication was well-tolerated with no skin thinning reported.Study Type:Clinical TrialStudied Population:Total Patients: 224Results:Halobetasol was significantly more effective than vehicle in treating chronic eczema
Halobetasol is generally safe and well-tolerated. Side effects are uncommon (occurring in only 2-5% of patients) and usually mild, mainly including skin dryness, itching, or burning sensations at the application site.
Summary:Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Study Type:Clinical TrialStudied Population:Total Patients: 264Severity: severeAge: Not specifiedResults:All three treatments showed similar high success rates
Summary:Halobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The cream improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.Study Type:Clinical TrialStudied Population:Total Patients: 111Severity: ChronicAge: Not specifiedResults:Significant improvement in all symptoms compared to vehicle (p<0.001)
The medication is available in both cream and ointment forms, and can be effective in both adults and children. In pediatric patients, it showed excellent results with 100% success rate for eczema treatment.
Summary:Halobetasol propionate cream was as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-93% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Study Type:Clinical TrialStudied Population:Total Patients: 264Severity: severeAge: Not specifiedResults:All three treatments showed similar high success rates
Halobetasol propionate is highly effective at treating eczema, with success rates (defined as 'healed' or 'marked improvement') ranging from 88% to 94% in various studies. It starts working quickly, with many patients seeing improvement within 3 days of starting treatment.
Summary:Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Study Type:Clinical TrialStudied Population:Total Patients: 264Severity: severeAge: Not availableResults:All three treatments showed similar high effectiveness
Summary:Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.Study Type:Clinical TrialStudied Population:Total Patients: 120Results:Halobetasol propionate showed better overall success rate
The medication is generally well-tolerated with a low rate of side effects (2-5% of patients). The most common side effects are skin dryness, itching, or burning at the application site.
Summary:Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Study Type:Clinical TrialStudied Population:Total Patients: 264Severity: severeAge: Not availableResults:All three treatments showed similar high effectiveness
Summary:Halobetasol propionate cream 0.05% was significantly more effective than placebo in treating atopic dermatitis symptoms when applied twice daily for 14 days. The medication improved itching, redness, scaling, and thickened skin, with benefits seen within 7 days of treatment.Study Type:Clinical TrialStudied Population:Total Patients: 111Results:Significant improvement in all symptoms compared to vehicle by day 7 and day 14 (p<0.001)
In children with severe eczema, the combination of halobetasol propionate cream during the day and ointment at night was extremely effective, with a 100% success rate. However, careful monitoring is needed as one case of mild skin thinning was reported.
The medication performs as well as or better than other strong topical steroids like clobetasol propionate and betamethasone dipropionate, making it a reliable option for treating severe eczema.
Summary:Halobetasol propionate cream was found to be as effective as two other steroid creams (clobetasol and betamethasone) in treating severe atopic dermatitis. About 88-90% of patients showed significant improvement, with effects starting within 3 days for about 40% of patients.Study Type:Clinical TrialStudied Population:Total Patients: 264Severity: severeAge: Not availableResults:All three treatments showed similar high effectiveness
Summary:Halobetasol propionate ointment was more effective than diflucortolone valerate ointment in treating severe atopic dermatitis, with 91.5% of patients showing significant improvement compared to 83.6%. It also worked faster, with 70% of patients seeing improvements within 3 days, and had fewer side effects.Study Type:Clinical TrialStudied Population:Total Patients: 120Results:Halobetasol propionate showed better overall success rate
-
LOWEST SIDE EFFECTSDesonide(Desonide)If you need a low-potency steroid treatmentIf you need a low-potency steroid treatmentTopical dailyLow
Side Effect Affected Cortisol suppression KEY TAKEAWAYSDesonide is effective at treating atopic dermatitis, with studies showing significant improvements in symptoms like itching and inflammation. When combined with moisturizers, it shows even better results with up to 100% effectiveness compared to 60% with desonide alone.Study Summary Study Type Studied Population Results Desonide is particularly safe for children, including infants. Studies show it rarely affects the body's natural hormone (cortisol) production, making it safer than stronger steroids like betamethasone.Study Summary Study Type Studied Population Results 📄Desonide hydrogel 0.05%, a low-potency steroid, was found to be safe and effective in treating children aged 6 months to 6 years with moderate-to-severe atopic dermatitis. The treatment showed good results in improving symptoms while having minimal impact on the body's hormone system.Clinical Trial Total Patients: 40Severity: moderate to severeAge: 6 months-6 yearsTreatment was generally safe with minimal impact on the body's hormone system 📄Both desonide 0.05% ointment and hydrocortisone 2.5% ointment were found to be safe for children with atopic dermatitis when used for 4 weeks. Neither medication affected the body's natural cortisol production system.Clinical Trial Both medications were safe for use in children and did not affect their natural cortisol production system 📄Both desonide cream 0.1% and betamethasone cream were equally effective in treating childhood atopic dermatitis. However, desonide had less impact on the body's cortisol levels, making it potentially safer for children.Clinical Trial Total Patients: 29Severity: Not specifiedAge: mean 13.8 monthsBoth treatments showed similar clinical effectiveness The hydrogel form of desonide helps improve skin moisture and barrier function, with significant improvements seen in as little as 1-2 weeks of treatment.Study Summary Study Type Studied Population Results 📄Desonide hydrogel 0.05% was found to be safe and effective in treating mild to moderate atopic dermatitis in children aged 3 months to 18 years. The treatment was well-tolerated and showed significant improvements compared to the vehicle (gel without medication).Clinical Trial Total Patients: 582The medication showed significant improvement compared to the vehicle alone When used with moisturizers, desonide can help prevent disease recurrence. Studies show this combination can extend the time before symptoms return to about 69 days compared to 49 days with desonide alone.Study Summary Study Type Studied Population Results -
LOWEST SIDE EFFECTSDesonide (Desonide)Who is this for?:If you need a low-potency steroid treatmentIf you need a low-potency steroid treatmentEffectiveness:Side Effects:LowCost:Delivery:Topical dailySee EvidenceGet This TreatmentKEY TAKEAWAYS
Desonide is effective at treating atopic dermatitis, with studies showing significant improvements in symptoms like itching and inflammation. When combined with moisturizers, it shows even better results with up to 100% effectiveness compared to 60% with desonide alone.
Desonide is particularly safe for children, including infants. Studies show it rarely affects the body's natural hormone (cortisol) production, making it safer than stronger steroids like betamethasone.
Summary:Desonide hydrogel 0.05%, a low-potency steroid, was found to be safe and effective in treating children aged 6 months to 6 years with moderate-to-severe atopic dermatitis. The treatment showed good results in improving symptoms while having minimal impact on the body's hormone system.Study Type:Clinical TrialStudied Population:Total Patients: 40Severity: moderate to severeAge: 6 months-6 yearsResults:Treatment was generally safe with minimal impact on the body's hormone system
Summary:Both desonide 0.05% ointment and hydrocortisone 2.5% ointment were found to be safe for children with atopic dermatitis when used for 4 weeks. Neither medication affected the body's natural cortisol production system.Study Type:Clinical TrialStudied Population:Results:Both medications were safe for use in children and did not affect their natural cortisol production system
Summary:Both desonide cream 0.1% and betamethasone cream were equally effective in treating childhood atopic dermatitis. However, desonide had less impact on the body's cortisol levels, making it potentially safer for children.Study Type:Clinical TrialStudied Population:Total Patients: 29Severity: Not specifiedAge: mean 13.8 monthsResults:Both treatments showed similar clinical effectiveness
The hydrogel form of desonide helps improve skin moisture and barrier function, with significant improvements seen in as little as 1-2 weeks of treatment.
Summary:Desonide hydrogel 0.05% was found to be safe and effective in treating mild to moderate atopic dermatitis in children aged 3 months to 18 years. The treatment was well-tolerated and showed significant improvements compared to the vehicle (gel without medication).Study Type:Clinical TrialStudied Population:Total Patients: 582Results:The medication showed significant improvement compared to the vehicle alone
When used with moisturizers, desonide can help prevent disease recurrence. Studies show this combination can extend the time before symptoms return to about 69 days compared to 49 days with desonide alone.
-
Clobetasol(Clobetasol propionate)If you need a super-high potency corticosteroid treatment (but should not be used for more than 2 weeks)If you need a super-high potency corticosteroid treatment (but should not be used for more than 2 weeks)Topical dailyMedium
Side Effect Affected Morning plasma cortisol reductions 6% KEY TAKEAWAYSClobetasol propionate is a highly effective treatment for eczema, with studies showing significant improvement in symptoms like redness, itching, and inflammation within 2-4 weeks of treatmentStudy Summary Study Type Studied Population Results 📄Clobetasol cream was more effective than fluocinonide cream in treating eczema when applied three times daily for 2 weeks. Clobetasol showed faster healing and fewer side effects (4%) compared to fluocinonide (12%).Clinical Trial Total Patients: 113Severity: not availableAge: adolescent and adultClobetasol showed faster healing and maintained efficacy, while fluocinonide's healing rate slowed after first week 📄Clobetasol propionate cream 0.05% was tested against a vehicle (cream without active ingredient) in patients with moderate-to-severe atopic dermatitis. The study lasted 4 weeks with twice daily application.Clinical Trial Total Patients: 81The medication can be safely used with minimal side effects when used as directed. Side effects, when they occur, are generally mild and affect about 4% of patientsStudy Summary Study Type Studied Population Results 📄Clobetasol cream was more effective than fluocinonide cream in treating eczema when applied three times daily for 2 weeks. Clobetasol showed faster healing and fewer side effects (4%) compared to fluocinonide (12%).Clinical Trial Total Patients: 113Severity: not availableAge: adolescent and adultClobetasol showed faster healing and maintained efficacy, while fluocinonide's healing rate slowed after first week 📄Clobetasol propionate, a very strong topical steroid, was more effective than flupredniden acetate (medium strength steroid) in preventing hand eczema from coming back. When using clobetasol twice weekly, 70% of patients remained free from eczema flares compared to 30% with flupredniden.Clinical Trial Total Patients: 55Clobetasol was more effective at preventing relapses than flupredniden Using clobetasol propionate twice weekly as maintenance therapy can help prevent relapses in chronic eczema, with studies showing it kept 70% of patients free from relapses during the observation periodStudy Summary Study Type Studied Population Results 📄Clobetasol propionate, a very strong topical steroid, was more effective than flupredniden acetate (medium strength steroid) in preventing hand eczema from coming back. When using clobetasol twice weekly, 70% of patients remained free from eczema flares compared to 30% with flupredniden.Clinical Trial Total Patients: 55Clobetasol was more effective at preventing relapses than flupredniden The medication comes in different forms (cream, lotion, ointment) with similar effectiveness, though the lotion form may provide better long-term results after stopping treatmentStudy Summary Study Type Studied Population Results Clobetasol propionate is highly effective at treating eczema, with success rates of over 90% in multiple studies. It typically starts working within a few days and can clear symptoms within 2-4 weeks of treatment.Study Summary Study Type Studied Population Results 📄Clobetasol propionate emollient cream 0.05% was tested against a placebo cream in patients with moderate-to-severe atopic dermatitis. The study lasted 4 weeks with twice daily application.Clinical Trial Total Patients: 81Severity: moderate to severeAge: ≥12 yearsnot available When used twice weekly for maintenance therapy, clobetasol can help prevent eczema from coming back. In one study, 70% of patients remained free from relapses using this approach.Study Summary Study Type Studied Population Results 📄Clobetasol propionate (a very strong steroid) was more effective than flupredniden acetate (a medium-strength steroid) in preventing hand eczema from coming back. When using clobetasol twice weekly, 70% of patients remained free from eczema flares compared to 30% with flupredniden.Clinical Trial Total Patients: 55Clobetasol was more effective at preventing relapses when used twice weekly While generally safe for short-term use, side effects can occur in about 4% of patients. These are usually mild but can include skin thinning and temporary changes in cortisol levels. Regular monitoring by a doctor is recommended for long-term use.Study Summary Study Type Studied Population Results 📄Clobetasol cream was more effective than fluocinonide cream in treating eczema when applied three times daily for 2 weeks. Clobetasol showed faster healing and fewer side effects (4%) compared to fluocinonide (12%).Clinical Trial Total Patients: 113Severity: not availableAge: adolescent and adultClobetasol showed faster healing and maintained efficacy, while fluocinonide's healing rate slowed after first week 📄Clobetasol propionate emollient cream 0.05% was tested against a placebo cream in patients with moderate-to-severe atopic dermatitis. The study lasted 4 weeks with twice daily application.Clinical Trial Total Patients: 81Severity: moderate to severeAge: ≥12 yearsnot available Different formulations (cream, lotion, emollient) appear to be similarly effective, though some studies suggest the lotion form may provide better long-term results than the cream version.Study Summary Study Type Studied Population Results -
Clobetasol (Clobetasol propionate)Who is this for?:If you need a super-high potency corticosteroid treatment (but should not be used for more than 2 weeks)If you need a super-high potency corticosteroid treatment (but should not be used for more than 2 weeks)Effectiveness:Side Effects:MediumCost:Delivery:Topical 2 dailySee EvidenceGet This TreatmentKEY TAKEAWAYS
Clobetasol propionate is a highly effective treatment for eczema, with studies showing significant improvement in symptoms like redness, itching, and inflammation within 2-4 weeks of treatment
Summary:Clobetasol cream was more effective than fluocinonide cream in treating eczema when applied three times daily for 2 weeks. Clobetasol showed faster healing and fewer side effects (4%) compared to fluocinonide (12%).Study Type:Clinical TrialStudied Population:Total Patients: 113Severity: not availableAge: adolescent and adultResults:Clobetasol showed faster healing and maintained efficacy, while fluocinonide's healing rate slowed after first week
Summary:Clobetasol propionate cream 0.05% was tested against a vehicle (cream without active ingredient) in patients with moderate-to-severe atopic dermatitis. The study lasted 4 weeks with twice daily application.Study Type:Clinical TrialStudied Population:Total Patients: 81Results:
The medication can be safely used with minimal side effects when used as directed. Side effects, when they occur, are generally mild and affect about 4% of patients
Summary:Clobetasol cream was more effective than fluocinonide cream in treating eczema when applied three times daily for 2 weeks. Clobetasol showed faster healing and fewer side effects (4%) compared to fluocinonide (12%).Study Type:Clinical TrialStudied Population:Total Patients: 113Severity: not availableAge: adolescent and adultResults:Clobetasol showed faster healing and maintained efficacy, while fluocinonide's healing rate slowed after first week
Summary:Clobetasol propionate, a very strong topical steroid, was more effective than flupredniden acetate (medium strength steroid) in preventing hand eczema from coming back. When using clobetasol twice weekly, 70% of patients remained free from eczema flares compared to 30% with flupredniden.Study Type:Clinical TrialStudied Population:Total Patients: 55Results:Clobetasol was more effective at preventing relapses than flupredniden
Using clobetasol propionate twice weekly as maintenance therapy can help prevent relapses in chronic eczema, with studies showing it kept 70% of patients free from relapses during the observation period
Summary:Clobetasol propionate, a very strong topical steroid, was more effective than flupredniden acetate (medium strength steroid) in preventing hand eczema from coming back. When using clobetasol twice weekly, 70% of patients remained free from eczema flares compared to 30% with flupredniden.Study Type:Clinical TrialStudied Population:Total Patients: 55Results:Clobetasol was more effective at preventing relapses than flupredniden
The medication comes in different forms (cream, lotion, ointment) with similar effectiveness, though the lotion form may provide better long-term results after stopping treatment
Clobetasol propionate is highly effective at treating eczema, with success rates of over 90% in multiple studies. It typically starts working within a few days and can clear symptoms within 2-4 weeks of treatment.
Summary:Clobetasol propionate emollient cream 0.05% was tested against a placebo cream in patients with moderate-to-severe atopic dermatitis. The study lasted 4 weeks with twice daily application.Study Type:Clinical TrialStudied Population:Total Patients: 81Severity: moderate to severeAge: ≥12 yearsResults:not available
When used twice weekly for maintenance therapy, clobetasol can help prevent eczema from coming back. In one study, 70% of patients remained free from relapses using this approach.
Summary:Clobetasol propionate (a very strong steroid) was more effective than flupredniden acetate (a medium-strength steroid) in preventing hand eczema from coming back. When using clobetasol twice weekly, 70% of patients remained free from eczema flares compared to 30% with flupredniden.Study Type:Clinical TrialStudied Population:Total Patients: 55Results:Clobetasol was more effective at preventing relapses when used twice weekly
While generally safe for short-term use, side effects can occur in about 4% of patients. These are usually mild but can include skin thinning and temporary changes in cortisol levels. Regular monitoring by a doctor is recommended for long-term use.
Summary:Clobetasol cream was more effective than fluocinonide cream in treating eczema when applied three times daily for 2 weeks. Clobetasol showed faster healing and fewer side effects (4%) compared to fluocinonide (12%).Study Type:Clinical TrialStudied Population:Total Patients: 113Severity: not availableAge: adolescent and adultResults:Clobetasol showed faster healing and maintained efficacy, while fluocinonide's healing rate slowed after first week
Summary:Clobetasol propionate emollient cream 0.05% was tested against a placebo cream in patients with moderate-to-severe atopic dermatitis. The study lasted 4 weeks with twice daily application.Study Type:Clinical TrialStudied Population:Total Patients: 81Severity: moderate to severeAge: ≥12 yearsResults:not available
Different formulations (cream, lotion, emollient) appear to be similarly effective, though some studies suggest the lotion form may provide better long-term results than the cream version.
Other Steroids Treatments
Treatment
Who is this for?
Delivery
Effectiveness
Side Effects
Estimated Cost
-
Betamethasone(Betamethasone)If you are 13 or older and responds to corticosteroidsIf you respond to corticosteroidsTopical dailyMedium
Side Effect Affected Skin thinning (atrophy) KEY TAKEAWAYSBetamethasone is effective at reducing inflammation and symptoms of eczema, with studies showing 76-94% of patients experiencing significant improvement within 2-3 weeks of treatment.Study Summary Study Type Studied Population Results 📄Both betamethasone and tacrolimus treatments effectively reduced eczema severity and inflammation. Betamethasone was better at reducing inflammation, while tacrolimus was better at improving skin hydration.Randomized Controlled Trial Total Patients: 36Severity: moderateAge: 18+Both treatments effectively reduced disease severity While betamethasone provides quick relief, long-term use may damage the skin barrier and cause skin thinning. It's better suited for short-term treatment of severe flares rather than long-term maintenance therapy.Study Summary Study Type Studied Population Results 📄Betamethasone was more effective at reducing inflammation compared to pimecrolimus in atopic dermatitis skin samples. However, betamethasone may impair skin barrier repair, while pimecrolimus helps maintain it, suggesting pimecrolimus might be better for long-term treatment.Clinical Trial Severity: not availableAge: not available📄Both betamethasone and pimecrolimus improved skin barrier function and reduced symptoms in atopic dermatitis. While betamethasone was better at reducing symptoms, it caused skin thinning, making pimecrolimus potentially better for long-term use.Randomized Controlled Trial Total Patients: 15Severity: not availableAge: not availableBetamethasone was more effective at reducing clinical symptoms 📄In people with controlled atopic dermatitis, betamethasone cream damaged the skin barrier after 4 weeks of use, while tacrolimus ointment improved skin barrier function. Tacrolimus was better at maintaining skin hydration and natural moisturizing factors.Randomized Controlled Trial Total Patients: 20Tacrolimus was superior to betamethasone for maintaining skin barrier health When combined with antibacterial agents like fusidic acid, betamethasone is more effective at treating infected eczema, eliminating 67% of bacteria compared to 51% with betamethasone alone.Study Summary Study Type Studied Population Results 📄A new cream containing fusidic acid and betamethasone (Fucicort Lipid cream) was found to be as effective as the existing cream formulation in treating infected atopic dermatitis. Both creams reduced severity scores by about 83% and cleared bacterial infection in about 90% of patients after 2 weeks of treatment.Randomized Controlled Trial Total Patients: 629Severity: Not specifiedAge: Not specifiedBoth Fucicort formulations showed similar effectiveness, significantly better than vehicle Alternative treatments like tacrolimus or pimecrolimus may be better for long-term use as they improve skin barrier function without causing the skin thinning associated with betamethasone.Study Summary Study Type Studied Population Results 📄Both tacrolimus and betamethasone improved skin barrier function during treatment. However, after stopping treatment, the benefits lasted longer with tacrolimus while the improvement from betamethasone partially wore off.Randomized Controlled Trial Total Patients: 21Severity: moderateAge: not availableBoth treatments improved skin barrier function, but tacrolimus benefits lasted longer after stopping treatment 📄Both betamethasone and pimecrolimus improved skin barrier function and reduced symptoms in atopic dermatitis. While betamethasone was better at reducing symptoms, it caused skin thinning, making pimecrolimus potentially better for long-term use.Randomized Controlled Trial Total Patients: 15Severity: not availableAge: not availableBetamethasone was more effective at reducing clinical symptoms 📄In people with controlled atopic dermatitis, betamethasone cream damaged the skin barrier after 4 weeks of use, while tacrolimus ointment improved skin barrier function. Tacrolimus was better at maintaining skin hydration and natural moisturizing factors.Randomized Controlled Trial Total Patients: 20Tacrolimus was superior to betamethasone for maintaining skin barrier health -
Betamethasone (Betamethasone)Who is this for?:If you respond to corticosteroidsIf you are 13 or older and responds to corticosteroidsEffectiveness:Side Effects:MediumCost:Delivery:Topical 1-2 dailySee EvidenceGet This TreatmentKEY TAKEAWAYS
Betamethasone is effective at reducing inflammation and symptoms of eczema, with studies showing 76-94% of patients experiencing significant improvement within 2-3 weeks of treatment.
While betamethasone provides quick relief, long-term use may damage the skin barrier and cause skin thinning. It's better suited for short-term treatment of severe flares rather than long-term maintenance therapy.
When combined with antibacterial agents like fusidic acid, betamethasone is more effective at treating infected eczema, eliminating 67% of bacteria compared to 51% with betamethasone alone.
Alternative treatments like tacrolimus or pimecrolimus may be better for long-term use as they improve skin barrier function without causing the skin thinning associated with betamethasone.
-
Elocon(Mometasone)If you respond to corticosteroids and need short-term relief through a very strong steroidIf you respond to corticosteroidsTopical dailyMedium
Side Effect Affected KEY TAKEAWAYSMometasone furoate cream is effective in treating atopic dermatitis, with success rates ranging from 80% to 90%. It can be used once daily, making it convenient for patients.Study Summary Study Type Studied Population Results 📄Using mometasone cream together with an Alginate Skin Repair Mask was more effective than using mometasone cream alone for treating atopic dermatitis. The combination treatment showed better results with 97.5% effectiveness compared to 80% for cream alone, and had fewer side effects and disease recurrences.Randomized Controlled Trial Total Patients: 80Severity: Not specifiedAge: 20-47 yearsCombination therapy resulted in significantly lower SCORAD scores The treatment is generally safe, especially in children. In studies, it showed minimal side effects and didn't affect children's growth when used as directed. Morning cortisol levels remained normal in most cases, indicating minimal impact on the body's hormone system.Study Summary Study Type Studied Population Results 📄In children with mild to moderate eczema, neither mometasone furoate 0.1% nor tacrolimus 0.1% affected their short-term growth rates. This suggests these treatments are safe to use in children without concerns about growth suppression.Randomized Controlled Trial Total Patients: 20Severity: mild to moderateAge: 5-12 yearsNo statistically significant effect on growth rate was observed with either treatment Long-term intermittent use (2-3 times per week) can help prevent disease recurrence. In one study, 83% of patients using it three times per week had no recurrences, compared to only 26% of those who stopped treatment completely.Study Summary Study Type Studied Population Results 📄Long-term intermittent treatment with mometasone furoate cream was effective for chronic hand eczema. Using the cream 3 times per week was more effective than using it 2 times per week or stopping treatment, with 83% of patients having no recurrence when using it 3 times weekly.Clinical Trial Total Patients: 120Severity: chronic hand eczemaAge: not availableThree-times-weekly maintenance therapy was most effective at preventing recurrence The effectiveness of mometasone can be enhanced when combined with other treatments. For example, using it with wet wrap dressings or skin repair masks showed better results than using mometasone alone.Study Summary Study Type Studied Population Results 📄Both mometasone and fluticasone ointments were effective in treating moderate to severe atopic dermatitis in children. Using wet wrap dressings after 2 weeks of treatment provided additional improvement in symptoms.Clinical Trial Total Patients: 40Severity: moderate to severeAge: children (age range not specified)Both treatments were effective, with additional benefits when wet wraps were added 📄Using mometasone cream together with an Alginate Skin Repair Mask was more effective than using mometasone cream alone for treating atopic dermatitis. The combination treatment showed better results with 97.5% effectiveness compared to 80% for cream alone, and had fewer side effects and disease recurrences.Randomized Controlled Trial Total Patients: 80Severity: Not specifiedAge: 20-47 yearsCombination therapy resulted in significantly lower SCORAD scores -
Elocon (Mometasone)Who is this for?:If you respond to corticosteroidsIf you respond to corticosteroids and need short-term relief through a very strong steroidEffectiveness:Side Effects:MediumCost:Delivery:Topical dailySee EvidenceGet This TreatmentKEY TAKEAWAYS
Mometasone furoate cream is effective in treating atopic dermatitis, with success rates ranging from 80% to 90%. It can be used once daily, making it convenient for patients.
The treatment is generally safe, especially in children. In studies, it showed minimal side effects and didn't affect children's growth when used as directed. Morning cortisol levels remained normal in most cases, indicating minimal impact on the body's hormone system.
Long-term intermittent use (2-3 times per week) can help prevent disease recurrence. In one study, 83% of patients using it three times per week had no recurrences, compared to only 26% of those who stopped treatment completely.
The effectiveness of mometasone can be enhanced when combined with other treatments. For example, using it with wet wrap dressings or skin repair masks showed better results than using mometasone alone.
-
Kenalog(Triamcinolone acetonide)If you are looking for short-term relief through a potent topical corticosteroidIf you are looking for short-term relief through a potent topical corticosteroidTopical dailyMedium
Side Effect Affected Local reactions skin irritation KEY TAKEAWAYSTriamcinolone acetonide is effective at reducing inflammation and improving symptoms of atopic dermatitis, with significant improvements seen within 2-4 weeks of treatmentStudy Summary Study Type Studied Population Results 📄A cream containing triamcinolone acetonide combined with laurocapram was more effective at treating atopic dermatitis compared to triamcinolone acetonide alone or vehicle control. The combination improved redness, skin thickness, and itching with minimal side effects.Clinical Trial Total Patients: 150TNX showed significantly higher improvement in signs and symptoms compared to both TN and vehicle control 📄Adding tetracycline to triamcinolone acetonide (a steroid) cream did not improve eczema symptoms more than using triamcinolone acetonide alone. However, the combination did reduce bacterial skin infection better than the steroid alone.Randomized Controlled Trial Total Patients: 44The medication is equally effective whether used as a cream or ointment with wet wraps, so patients can choose the form they prefer. While ointments were harder to apply, patients often preferred them for future useStudy Summary Study Type Studied Population Results 📄Both cream and ointment forms of triamcinolone acetonide were equally effective when used with wet wraps for treating atopic dermatitis in children. While patients found the ointment more difficult to apply, they preferred it for future treatments.Randomized Controlled Trial Total Patients: 39Severity: not availableAge: pediatricNo significant difference in effectiveness between cream and ointment formulations Triamcinolone acetonide appears to be safe, with only minor local reactions reported in a small number of patients (around 4-6% of users)Study Summary Study Type Studied Population Results 📄A cream containing triamcinolone acetonide combined with laurocapram was more effective at treating atopic dermatitis compared to triamcinolone acetonide alone or vehicle control. The combination improved redness, skin thickness, and itching with minimal side effects.Clinical Trial Total Patients: 150TNX showed significantly higher improvement in signs and symptoms compared to both TN and vehicle control Surprisingly, even very low doses of triamcinolone acetonide (40 times lower than typical commercial products) can be effective at reducing inflammation in mild to moderate atopic dermatitisStudy Summary Study Type Studied Population Results 📄A low-dose steroid cream (triamcinolone acetonide) at 25 microg/g concentration was effective in treating mild to moderate atopic dermatitis. The low-dose steroid showed significant improvement compared to the cream without steroid after just one week of treatment.Randomized Controlled Trial Total Patients: 14Low-dose steroid cream showed significant improvement in SCORAD scores starting from week 1, while the plain cream showed no improvement -
Kenalog (Triamcinolone acetonide)Who is this for?:If you are looking for short-term relief through a potent topical corticosteroidIf you are looking for short-term relief through a potent topical corticosteroidEffectiveness:Side Effects:MediumCost:Delivery:Topical 1-2 dailySee EvidenceGet This TreatmentKEY TAKEAWAYS
Triamcinolone acetonide is effective at reducing inflammation and improving symptoms of atopic dermatitis, with significant improvements seen within 2-4 weeks of treatment
The medication is equally effective whether used as a cream or ointment with wet wraps, so patients can choose the form they prefer. While ointments were harder to apply, patients often preferred them for future use
Triamcinolone acetonide appears to be safe, with only minor local reactions reported in a small number of patients (around 4-6% of users)
Surprisingly, even very low doses of triamcinolone acetonide (40 times lower than typical commercial products) can be effective at reducing inflammation in mild to moderate atopic dermatitis
-
Hydrocortisone cream(Hydrocortisone)For temporary relief of itch and rashesFor temporary relief of itch and rashesTopical dailyMedium
Side Effect Affected Adrenal suppression 8% Burning sensation 2% Cutaneous reactions Skin burning ($5.80 - $20)KEY TAKEAWAYSTopical corticosteroids are effective as a first-line treatment for atopic dermatitis, with studies showing significant improvement in symptoms within weeks of proper useStudy Summary Study Type Studied Population Results 📄A spray form of the steroid desoximetasone was tested in adults with atopic dermatitis. The spray significantly reduced itch and improved symptoms within 1 week, and these improvements lasted throughout the 4-week study. No side effects were reported.Clinical Trial Severity: not availableAge: 18+Skin appearance improved within 1 week and stayed better for 4 weeks 📄The study compared two ways of applying steroid cream in children with eczema - either on wet skin after a bath (soak and smear) or on dry skin. Both methods worked equally well, improving eczema by about 80-85%.Randomized Controlled Trial Total Patients: 45Severity: not availableAge: children (specific range not available)Both methods of applying topical corticosteroids (wet vs. dry skin) showed similar effectiveness 📄Using a strong steroid cream (fluticasone) worked better than a mild steroid cream (hydrocortisone) for treating moderate eczema flare-ups in children. Children using the stronger steroid had better symptom improvement and quality of life over 24 weeks.Randomized Controlled Trial Total Patients: 32Severity: moderateAge: 3 months-17 yearsStrong steroid showed significantly better symptom control throughout the study period Potent (stronger) topical corticosteroids may be more effective than mild ones for moderate flare-ups, showing better symptom improvement and quality of life scores over 24 weeksStudy Summary Study Type Studied Population Results 📄Using a strong steroid cream (fluticasone) worked better than a mild steroid cream (hydrocortisone) for treating moderate eczema flare-ups in children. Children using the stronger steroid had better symptom improvement and quality of life over 24 weeks.Randomized Controlled Trial Total Patients: 32Severity: moderateAge: 3 months-17 yearsStrong steroid showed significantly better symptom control throughout the study period The method of applying topical steroids (whether to wet or dry skin) does not significantly affect treatment outcomes, suggesting flexibility in application methodsStudy Summary Study Type Studied Population Results 📄The study compared two ways of applying steroid cream in children with eczema - either on wet skin after a bath (soak and smear) or on dry skin. Both methods worked equally well, improving eczema by about 80-85%.Randomized Controlled Trial Total Patients: 45Severity: not availableAge: children (specific range not available)Both methods of applying topical corticosteroids (wet vs. dry skin) showed similar effectiveness -
Hydrocortisone cream (Hydrocortisone)Who is this for?:For temporary relief of itch and rashesFor temporary relief of itch and rashesEffectiveness:Side Effects:MediumCost:Delivery:Topical 1-4 dailySee EvidenceGet This TreatmentKEY TAKEAWAYS
Topical corticosteroids are effective as a first-line treatment for atopic dermatitis, with studies showing significant improvement in symptoms within weeks of proper use
Potent (stronger) topical corticosteroids may be more effective than mild ones for moderate flare-ups, showing better symptom improvement and quality of life scores over 24 weeks
The method of applying topical steroids (whether to wet or dry skin) does not significantly affect treatment outcomes, suggesting flexibility in application methods
-
Fluocinonide(Fluocinonide)If you need a strong topical steroidIf you need a strong topical steroidTopical dailyMedium
Side Effect Affected mild drug-related effects 12% burning sensation 4% KEY TAKEAWAYSFluocinonide cream is effective at treating atopic dermatitis, with studies showing significant improvement in symptoms like itching and rash severity within 2 weeks of treatment. In one study, itching decreased by 79% and overall severity decreased by 76%.Study Summary Study Type Studied Population Results 📄A 3-day treatment with fluocinonide cream showed high patient adherence (100%) and significant improvement in eczema symptoms. By day 14, patients experienced 79% reduction in itching and 76% improvement in eczema severity, with more than half of patients achieving clear or almost clear skin.Clinical Trial Total Patients: 20Severity: mild to severeAge: not availableSignificant reduction in itching after treatment 📄A two-week treatment with fluocinonide 0.1% cream improved skin barrier function and reduced symptoms in patients with moderate-to-severe atopic dermatitis. 28% of patients achieved clear or almost clear skin after treatment.Clinical Trial Total Patients: 25Significant improvement in eczema severity Once-daily application of fluocinonide appears to be as effective as twice-daily use, with a lower risk of side effects. The medication is generally well-tolerated, though some patients may experience mild burning sensation during the first few days of use.Study Summary Study Type Studied Population Results 📄A two-week treatment with fluocinonide 0.1% cream improved skin barrier function and reduced symptoms in patients with moderate-to-severe atopic dermatitis. 28% of patients achieved clear or almost clear skin after treatment.Clinical Trial Total Patients: 25Significant improvement in eczema severity 📄Fluocinonide cream 0.1% was found to be safe and effective when used once daily in children with moderate to severe atopic dermatitis. Over 90% of patients showed improvement in their condition, and applying it once daily was as effective as twice daily with lower risk of side effects.Randomized Controlled Trial Treatment was highly effective with both once-daily and twice-daily application Short-term use (2-3 weeks) of fluocinonide actually helps improve the skin barrier function in people with atopic dermatitis, though long-term use should be avoided as it can cause skin thinning.Study Summary Study Type Studied Population Results 📄A two-week treatment with fluocinonide 0.1% cream improved skin barrier function and reduced symptoms in patients with moderate-to-severe atopic dermatitis. 28% of patients achieved clear or almost clear skin after treatment.Clinical Trial Total Patients: 25Significant improvement in eczema severity Studies show fluocinonide is more effective than some other topical steroids like halcinonide for treating atopic dermatitis.Study Summary Study Type Studied Population Results -
Fluocinonide (Fluocinonide)Who is this for?:If you need a strong topical steroidIf you need a strong topical steroidEffectiveness:Side Effects:MediumCost:Delivery:Topical dailySee EvidenceDiscuss with a DermatologistKEY TAKEAWAYS
Fluocinonide cream is effective at treating atopic dermatitis, with studies showing significant improvement in symptoms like itching and rash severity within 2 weeks of treatment. In one study, itching decreased by 79% and overall severity decreased by 76%.
Once-daily application of fluocinonide appears to be as effective as twice-daily use, with a lower risk of side effects. The medication is generally well-tolerated, though some patients may experience mild burning sensation during the first few days of use.
Short-term use (2-3 weeks) of fluocinonide actually helps improve the skin barrier function in people with atopic dermatitis, though long-term use should be avoided as it can cause skin thinning.
Studies show fluocinonide is more effective than some other topical steroids like halcinonide for treating atopic dermatitis.
-
Prednisone(Prednisone)If you're open to steroids and growth suppression is not a concernIf you're open to steroids and topical treatments haven't worked for youOral dailyMedium
Side Effect Affected Sodium retention 9999% Congestive heart failure 9999% Muscle weakness 9999% Osteoporosis 9999% KEY TAKEAWAYSOral prednisolone is not recommended as a first-line treatment for severe adult eczema. In a direct comparison study, ciclosporin was found to be significantly more effective than prednisolone for treating severe eczema in adults.Study Summary Study Type Studied Population Results 📄Ciclosporin was found to be more effective than prednisolone for treating severe eczema in adults. Only 1 out of 21 patients on prednisolone achieved stable improvement compared to 6 out of 17 patients on ciclosporin. The study was stopped early due to many patients on prednisolone experiencing significant worsening of their eczema.Randomized Controlled Trial Total Patients: 38Ciclosporin was significantly more effective than prednisolone Topical forms of prednisolone (like methylprednisolone aceponate) can be effective for treating eczema flares and preventing relapses. When used twice weekly along with moisturizers, it reduced the risk of flares by 87% over 16 weeks.Study Summary Study Type Studied Population Results 📄Using methylprednisolone aceponate cream twice weekly along with moisturizer was more effective at preventing eczema flares than using moisturizer alone. After 16 weeks, 87.1% of patients using the steroid cream remained free from flares compared to 65.8% using just moisturizer.Randomized Controlled Trial Total Patients: 249Patients using the steroid cream were 3.5 times less likely to experience a relapse Topical methylprednisolone aceponate provides fast itch relief, with patients experiencing significant reduction in itching within 1-2 days of starting treatment.Study Summary Study Type Studied Population Results 📄In a study of experimental eczema caused by nickel allergy, methylprednisolone aceponate (a topical corticosteroid) provided fast itch relief. On average, significant itch relief was achieved within 1 day of treatment.Clinical Trial Total Patients: 16Severity: not availableAge: not availableTreatment provided fast and effective itch relief In children and adolescents with severe eczema, topical methylprednisolone aceponate 0.1% was found to be as effective as tacrolimus 0.03% for overall improvement, and better for reducing itch and improving sleep. It also had fewer side effects and lower cost.Study Summary Study Type Studied Population Results 📄Both methylprednisolone aceponate 0.1% ointment and tacrolimus 0.03% ointment were effective in treating severe atopic dermatitis in children and adolescents. Methylprednisolone showed better results for reducing itch and improving sleep, and was more cost-effective.Randomized Controlled Trial Total Patients: 265Severity: severe to very severeAge: children and adolescentsBoth treatments were equally effective in achieving clear or almost clear skin -
Prednisone (Prednisone)Who is this for?:If you're open to steroids and topical treatments haven't worked for youIf you're open to steroids and growth suppression is not a concernEffectiveness:Side Effects:MediumCost:Delivery:Oral dailySee EvidenceGet This TreatmentKEY TAKEAWAYS
Oral prednisolone is not recommended as a first-line treatment for severe adult eczema. In a direct comparison study, ciclosporin was found to be significantly more effective than prednisolone for treating severe eczema in adults.
Topical forms of prednisolone (like methylprednisolone aceponate) can be effective for treating eczema flares and preventing relapses. When used twice weekly along with moisturizers, it reduced the risk of flares by 87% over 16 weeks.
Topical methylprednisolone aceponate provides fast itch relief, with patients experiencing significant reduction in itching within 1-2 days of starting treatment.
In children and adolescents with severe eczema, topical methylprednisolone aceponate 0.1% was found to be as effective as tacrolimus 0.03% for overall improvement, and better for reducing itch and improving sleep. It also had fewer side effects and lower cost.
Eczema is more than skin deep
Join our waitlist while we set up personalized holistic eczema care.
Choose Your Preferences to Optimize Your Treatment
Age
Eczema Severity Level
Max Side Effects Tolerated
Insurance Coverage
Include Steroidal Creams